BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 3081600)

  • 1. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
    Feighner J; Hendrickson G; Miller L; Stern W
    J Clin Psychopharmacol; 1986 Feb; 6(1):27-32. PubMed ID: 3081600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
    Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of placebo-controlled trials with bupropion.
    Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the safety and efficacy of bupropion in depression.
    Halaris AE; Stern WC; Van Wyck Fleet J; Reno RM
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):101-3. PubMed ID: 6406435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion in depression: a tri-center placebo-controlled study.
    Pitts WM; Fann WE; Halaris AE; Dressler DM; Sajadi C; Snyder S; Ilaria RL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):95-100. PubMed ID: 6406473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of bupropion.
    Othmer E; Othmer SC; Stern WC; Van Wyck Fleet J
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):153-6. PubMed ID: 6406448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants.
    Gardner EA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):157-62. PubMed ID: 6406449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Private practice evaluation of the safety and efficacy of bupropion in depressed outpatients.
    Kirksey DF; Harto-Truax N
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):143-7. PubMed ID: 6406446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.
    Lineberry CG; Johnston JA; Raymond RN; Samara B; Feighner JP; Harto NE; Granacher RP; Weisler RH; Carman JS; Boyer WF
    J Clin Psychiatry; 1990 May; 51(5):194-9. PubMed ID: 2110559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
    Feighner JP; Cohn JB
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):20-5. PubMed ID: 3882676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset of action of amoxapine and doxepin in outpatients with "mixed anxiety/depression".
    Hekimian LJ; Weise CC; Friedhoff AJ
    J Clin Psychiatry; 1983 Jul; 44(7):248-52. PubMed ID: 6863224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of bupropion in hospitalized depressed patients.
    Merideth CH; Feighner JP
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):85-7. PubMed ID: 6406471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of bupropion in tricyclic-resistant or intolerant patients.
    Stern WC; Harto-Truax N; Bauer N
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):148-52. PubMed ID: 6406447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxepin's effects on chronic pain and depression: a controlled study.
    Hameroff SR; Weiss JL; Lerman JC; Cork RC; Watts KS; Crago BR; Neuman CP; Womble JR; Davis TP
    J Clin Psychiatry; 1984 Mar; 45(3 Pt 2):47-53. PubMed ID: 6321454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.